A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death.

West, Thomas J; Bi, Junfeng; Martínez-Peña, Francisco; Curtis, Ellis J; Gazaniga, Nathalia R; Mischel, Paul S; Lairson, Luke L

West, Thomas J; Bi, Junfeng; Martínez-Peña, Francisco; Curtis, Ellis J; Gazaniga, Nathalia R; Mischel, Paul S; Lairson, Luke L.

Afiliação

West TJ; Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.
Bi J; Department of Pathology, School of Medicine, Stanford University, Stanford, California 94305, United States.
Martínez-Peña F; Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.
Curtis EJ; Department of Pathology, School of Medicine, Stanford University, Stanford, California 94305, United States.
Gazaniga NR; Department of Medicine, UCSD School of Medicine, La Jolla, California 92093, United States.
Mischel PS; Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.
Lairson LL; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California 92037, United States.

J Am Chem Soc ; 2023 Apr 05.

Article em En | MEDLINE | ID: mdl-37017374

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Am Chem Soc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos